⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALLO News

Allogene Therapeutics, Inc. Common Stock

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting